{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:57:59Z","timestamp":1794272279354,"version":"4.9.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary Sj\u00f6gren\u2019s Syndrome (pSS) is a systemic chronic autoimmune disorder that contributes to dry mouth (xerostomia) and eyes (xerophthalmia). It mainly affects females between 40 and 60 years old. So far, there is no treatment to cure SS; however, there is a list of medications that can ameliorate the symptoms. In addition, there has been no single test until now to detect pSS, but clinical and immunological investigations are applied as diagnostic tools. Therefore, this study aimed to explore the characteristics of pSS in Saudi patients based on the onset of the disease through laboratory findings and pharmaceutical management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>This retrospective study examined diagnosed patients with pSS between 2018 and 2023 from the National Guard Hospital, Saudi Arabia. Data of pSS patients was categorized into two groups: early (under 40 years old) and late-onset (40 years old and above). Data on demographic information, mortality rate, and blood tests such as complete blood count (CBC), creatinine, erythrocyte sedimentation rate (ESR), and vitamin levels, in addition to prescribed medications, were collected from the patient\u2019s medical record. Chi-square and t-tests were mainly used, and statistical significance was determined at a <jats:italic>P<\/jats:italic>-value less than 0.05.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 453 patients were included in the study, where the early-onset group comprised 136 and the late-onset group comprised 317 patients. The mean age of the early and late onset was 34.2 and 60.4, respectively. ESR was significantly higher in the early (46.3\u00a0mm\/hr) and late-onset (49.8\u00a0mm\/hr). The most common medication used by all pSS patients was hydroxychloroquine. However, artificial tears were mainly observed in the late-onset group. Other medications, such as pilocarpine, methotrexate, and azathioprine, were prescribed to pSS patients to a lesser extent.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study suggests that the onset of pSS could occur even before the age of 40 among Saudi citizens. Notably, elevated ESR levels appeared to be a feature of pSS, which was consistent with other previous findings. The variability of some medications between early-onset and late-onset pSS may indicate disease progression. However, further investigations are required to confirm this observation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00296-024-05626-0","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T16:03:48Z","timestamp":1717603428000},"page":"1317-1325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Laboratory features and pharmacological management of early and late-onset primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4654-245X","authenticated-orcid":false,"given":"Rimah A.","family":"Saleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9838-2155","authenticated-orcid":false,"given":"Majed","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2675-7211","authenticated-orcid":false,"given":"Yasmin","family":"Elshaaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3736-5989","authenticated-orcid":false,"given":"Hatouf","family":"Sukkarieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2356-9069","authenticated-orcid":false,"given":"Rasha","family":"Alissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4976-4194","authenticated-orcid":false,"given":"Noara","family":"Alhusseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2019-4362","authenticated-orcid":false,"given":"Hani","family":"Tamim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8266-6145","authenticated-orcid":false,"given":"Awad","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2577-6868","authenticated-orcid":false,"given":"Hesham","family":"Almaimoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"issue":"1","key":"5626_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S et al (2022) Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med 22(1):9\u201325","journal-title":"Clin Exp Med"},{"issue":"5","key":"5626_CR2","doi-asserted-by":"publisher","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","volume":"9","author":"CP Mavragani","year":"2010","unstructured":"Mavragani CP, Moutsopoulos HM (2010) The geoepidemiology of Sj\u00f6gren\u2019s syndrome. Autoimmun Rev 9(5):A305\u2013A310","journal-title":"Autoimmun Rev"},{"issue":"5","key":"5626_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","volume":"53","author":"C Baldini","year":"2014","unstructured":"Baldini C et al (2014) Primary Sjogren\u2019s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford) 53(5):839\u2013844","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"5626_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","volume":"12","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P et al (2016) Early diagnosis of primary Sj\u00f6gren\u2019s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol 12(2):137\u2013156","journal-title":"Expert Rev Clin Immunol"},{"key":"5626_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/OARRR.S284985","volume":"12","author":"F AlEnzi","year":"2020","unstructured":"AlEnzi F et al (2020) Fatigue in Saudi patients with primary Sj\u00f6gren\u2019s syndrome and its correlation with Disease characteristics and outcome measures: a cross-sectional study. Open Access Rheumatol 12:303\u2013308","journal-title":"Open Access Rheumatol"},{"issue":"9482","key":"5626_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI (2005) Sj\u00f6gren\u2019s syndrome. Lancet 366(9482):321\u2013331","journal-title":"Lancet"},{"issue":"3","key":"5626_CR7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s40744-021-00334-8","volume":"8","author":"Z Liu","year":"2021","unstructured":"Liu Z, Chu A (2021) Sj\u00f6gren\u2019s syndrome and viral infections. Rheumatol Therapy 8(3):1051\u20131059","journal-title":"Rheumatol Therapy"},{"issue":"1","key":"5626_CR8","doi-asserted-by":"publisher","first-page":"10627","DOI":"10.1038\/s41598-020-67462-z","volume":"10","author":"J Narv\u00e1ez","year":"2020","unstructured":"Narv\u00e1ez J et al (2020) Prevalence of Sj\u00f6gren\u2019s syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases. Sci Rep 10(1):10627","journal-title":"Sci Rep"},{"issue":"11","key":"5626_CR9","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin B et al (2015) Epidemiology of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1983\u20131989","journal-title":"Ann Rheum Dis"},{"key":"5626_CR10","doi-asserted-by":"publisher","first-page":"102364","DOI":"10.1016\/j.jaut.2019.102364","volume":"110","author":"CP Mavragani","year":"2020","unstructured":"Mavragani CP, Moutsopoulos HM (2020) Sj\u00f6gren\u2019s syndrome: Old and new therapeutic targets. J Autoimmun 110:102364","journal-title":"J Autoimmun"},{"issue":"4","key":"5626_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","volume":"10","author":"FG Kroese","year":"2014","unstructured":"Kroese FG et al (2014) B-cell hyperactivity in primary Sj\u00f6gren\u2019s syndrome. Expert Rev Clin Immunol 10(4):483\u2013499","journal-title":"Expert Rev Clin Immunol"},{"key":"5626_CR12","doi-asserted-by":"publisher","first-page":"676885","DOI":"10.3389\/fmed.2021.676885","volume":"8","author":"C Vitali","year":"2021","unstructured":"Vitali C et al (2021) Management of Sj\u00f6gren\u2019s syndrome: Present issues and Future perspectives. Front Med (Lausanne) 8:676885","journal-title":"Front Med (Lausanne)"},{"key":"5626_CR13","doi-asserted-by":"crossref","unstructured":"Parisis D et al (2020) Current State of Knowledge on Primary Sj\u00f6gren\u2019s Syndrome, an Autoimmune Exocrinopathy. J Clin Med, 9(7)","DOI":"10.3390\/jcm9072299"},{"issue":"8","key":"5626_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41584-021-00634-x","volume":"17","author":"R Seror","year":"2021","unstructured":"Seror R, Nocturne G, Mariette X (2021) Current and future therapies for primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 17(8):475\u2013486","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"5626_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1191\/096120398678920019","volume":"7","author":"M Ramos-Casals","year":"1998","unstructured":"Ramos-Casals M et al (1998) Young onset of primary Sj\u00f6gren\u2019s syndrome: clinical and immunological characteristics. Lupus 7(3):202\u2013206","journal-title":"Lupus"},{"issue":"7","key":"5626_CR16","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/rheumatology\/key392","volume":"58","author":"C Anquetil","year":"2019","unstructured":"Anquetil C et al (2019) Is early-onset primary Sj\u00f6gren\u2019s syndrome a worse prognosis form of the disease? Rheumatology 58(7):1163\u20131167","journal-title":"Rheumatology"},{"key":"5626_CR17","doi-asserted-by":"publisher","first-page":"594096","DOI":"10.3389\/fimmu.2020.594096","volume":"11","author":"AV Goules","year":"2020","unstructured":"Goules AV et al (2020) Primary Sj\u00f6gren\u2019s syndrome of early and late onset: distinct clinical phenotypes and Lymphoma Development. Front Immunol 11:594096","journal-title":"Front Immunol"},{"issue":"4","key":"5626_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/MD.0b013e318181e6af","volume":"87","author":"M Ramos-Casals","year":"2008","unstructured":"Ramos-Casals M et al (2008) Primary Sj\u00f6gren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine 87(4):210\u2013219","journal-title":"Medicine"},{"issue":"3","key":"5626_CR19","doi-asserted-by":"publisher","first-page":"e13992","DOI":"10.1111\/ijcp.13992","volume":"75","author":"F Y\u0131ld\u0131z","year":"2021","unstructured":"Y\u0131ld\u0131z F, G\u00f6kmen O (2021) Haematologic indices and disease activity index in primary Sjogren\u2019s syndrome. Int J Clin Pract 75(3):e13992","journal-title":"Int J Clin Pract"},{"issue":"4","key":"5626_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3177\/jnsv.66.386","volume":"66","author":"C-Y Kuo","year":"2020","unstructured":"Kuo C-Y et al (2020) Vitamin d deficiency is associated with severity of dry eye symptoms and primary sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. J Nutri Sci Vitaminol 66(4):386\u2013388","journal-title":"J Nutri Sci Vitaminol"},{"issue":"6","key":"5626_CR21","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.amjmed.2005.09.015","volume":"119","author":"E Andr\u00e8s","year":"2006","unstructured":"Andr\u00e8s E et al (2006) Primary Sj\u00f6gren\u2019s syndrome and vitamin B12 deficiency: preliminary results in 80 patients. Am J Med 119(6):e9\u2013e10","journal-title":"Am J Med"},{"issue":"7","key":"5626_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2012.53","volume":"8","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M et al (2012) Topical and systemic medications for the treatment of primary Sj\u00f6gren\u2019s syndrome. Nat Rev Rheumatol 8(7):399\u2013411","journal-title":"Nat Rev Rheumatol"},{"key":"5626_CR23","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s10067-018-4153-8","volume":"37","author":"X Chen","year":"2018","unstructured":"Chen X, Wu H, Wei W (2018) Advances in the diagnosis and treatment of Sjogren\u2019s syndrome. Clin Rheumatol 37:1743\u20131749","journal-title":"Clin Rheumatol"},{"issue":"8","key":"5626_CR24","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nrrheum.2016.100","volume":"12","author":"A Saraux","year":"2016","unstructured":"Saraux A, Pers J-O, Devauchelle-Pensec V (2016) Treatment of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol 12(8):456\u2013471","journal-title":"Nat Rev Rheumatol"},{"key":"5626_CR25","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s10067-017-3822-3","volume":"36","author":"J Demarchi","year":"2017","unstructured":"Demarchi J et al (2017) Primary Sj\u00f6gren\u2019s syndrome: extraglandular manifestations and hydroxychloroquine therapy. Clin Rheumatol 36:2455\u20132460","journal-title":"Clin Rheumatol"},{"key":"5626_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaut.2014.02.006","volume":"51","author":"D Cornec","year":"2014","unstructured":"Cornec D, Jamin C, Pers J-O (2014) Sj\u00f6gren\u2019s syndrome: where do we stand, and where shall we go? J Autoimmun 51:109\u2013114","journal-title":"J Autoimmun"},{"issue":"12","key":"5626_CR27","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","volume":"164","author":"SS Kassan","year":"2004","unstructured":"Kassan SS, Moutsopoulos HM (2004) Clinical manifestations and early diagnosis of Sj\u00f6gren syndrome. Arch Intern Med 164(12):1275\u20131284","journal-title":"Arch Intern Med"},{"key":"5626_CR28","first-page":"247","volume":"6","author":"R Patel","year":"2014","unstructured":"Patel R, Shahane A (2014) The epidemiology of Sj\u00f6gren\u2019s syndrome. Clin Epidemiol 6:247\u2013255","journal-title":"Clin Epidemiol"},{"issue":"4","key":"5626_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40266-021-00838-6","volume":"38","author":"S Retamozo","year":"2021","unstructured":"Retamozo S et al (2021) Therapeutic recommendations for the management of older adult patients with Sj\u00f6gren\u2019s syndrome. Drugs Aging 38(4):265\u2013284","journal-title":"Drugs Aging"},{"issue":"4","key":"5626_CR30","doi-asserted-by":"publisher","first-page":"105132","DOI":"10.1016\/j.jbspin.2021.105132","volume":"88","author":"KA Lee","year":"2021","unstructured":"Lee KA et al (2021) Elderly-onset primary Sj\u00f6gren\u2019s syndrome focused on clinical and salivary gland ultrasonographic features. Joint Bone Spine 88(4):105132","journal-title":"Joint Bone Spine"},{"issue":"5","key":"5626_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s40744-022-00476-3","volume":"9","author":"H-X Li","year":"2022","unstructured":"Li H-X et al (2022) Characteristics of patients with primary Sj\u00f6gren\u2019s syndrome and non-specific chronic sialadenitis: a subtype in Elderly patients. Rheumatol Therapy 9(5):1347\u20131359","journal-title":"Rheumatol Therapy"},{"issue":"10","key":"5626_CR32","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1093\/rheumatology\/keab032","volume":"60","author":"M Ramos-Casals","year":"2021","unstructured":"Ramos-Casals M et al (2021) Childhood-onset of primary Sj\u00f6gren\u2019s syndrome: phenotypic characterization at diagnosis of 158 children. Rheumatology (Oxford) 60(10):4558\u20134567","journal-title":"Rheumatology (Oxford)"},{"key":"5626_CR33","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s10067-020-05017-3","volume":"39","author":"ME Yayla","year":"2020","unstructured":"Yayla ME et al (2020) Early onset primary Sj\u00f6gren syndrome, clinical and laboratory characteristics. Clin Rheumatol 39:2689\u20132696","journal-title":"Clin Rheumatol"},{"issue":"2","key":"5626_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","volume":"65","author":"O Bjordal","year":"2020","unstructured":"Bjordal O et al (2020) Primary Sj\u00f6gren\u2019s syndrome and the eye. Surv Ophthalmol 65(2):119\u2013132","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"5626_CR35","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1177\/0961203317696593","volume":"26","author":"R Aljohani","year":"2017","unstructured":"Aljohani R et al (2017) Disease evolution in late-onset and early-onset systemic lupus erythematosus. Lupus 26(11):1190\u20131196","journal-title":"Lupus"},{"issue":"6","key":"5626_CR36","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.55563\/clinexprheumatol\/egnd1i","volume":"39","author":"S Retamozo","year":"2021","unstructured":"Retamozo S et al (2021) Influence of the age at diagnosis in the disease expression of primary Sj\u00f6gren syndrome. Analysis of 12,753 patients from the Sj\u00f6gren Big Data Consortium. Clin Exp Rheumatol 39(6):S166\u2013S174","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 2","key":"5626_CR37","first-page":"790","volume":"78","author":"O Argyropoulou","year":"2019","unstructured":"Argyropoulou O et al (2019) FRI0222\u2005ANALYSIS OF CLINICAL AND SEROLOGICAL PICTURE OF PATIENTS WITH PRIMARY SJ\u00f6GREN\u2019S SYNDROMEAND AN EARLY DISEASE ONSET AT AGE BEFORE 35 YEARS. Ann Rheum Dis 78(Suppl 2):790\u2013791","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"5626_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jbspin.2010.05.008","volume":"78","author":"C Botsios","year":"2011","unstructured":"Botsios C et al (2011) Elderly onset of primary Sj\u00f6gren\u2019s syndrome: clinical manifestations, serological features and oral\/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine 78(2):171\u2013174","journal-title":"Joint Bone Spine"},{"issue":"6","key":"5626_CR39","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/annrheumdis-2016-209952","volume":"76","author":"P Brito-Zer\u00f3n","year":"2017","unstructured":"Brito-Zer\u00f3n P et al (2017) Influence of geolocation and ethnicity on the phenotypic expression of primary Sj\u00f6gren\u2019s syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sj\u00f6gren Project Consortium. Ann Rheum Dis 76(6):1042\u20131050","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5626_CR40","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/acr.22115","volume":"66","author":"C Maldini","year":"2014","unstructured":"Maldini C et al (2014) Epidemiology of primary Sj\u00f6gren\u2019s syndrome in a French multiracial\/multiethnic area. Arthritis Care Res (Hoboken) 66(3):454\u2013463","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"5626_CR41","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1037\/amp0000388","volume":"73","author":"JK Kiecolt-Glaser","year":"2018","unstructured":"Kiecolt-Glaser JK (2018) Marriage, divorce, and the immune system. Am Psychol 73(9):1098\u20131108","journal-title":"Am Psychol"},{"key":"5626_CR42","doi-asserted-by":"crossref","unstructured":"Meng F et al (2021) Association between Stressful Life Events and female primary Sjogren\u2019s syndrome and their role in Disease Activity: a retrospective case\u2013control study in China. Neuropsychiatr Dis Treat, : p. 213\u2013220","DOI":"10.2147\/NDT.S287798"},{"issue":"3","key":"5626_CR43","first-page":"450","volume":"55","author":"AG Singh","year":"2016","unstructured":"Singh AG, Singh S, Matteson EL (2016) Rate, risk factors and causes of mortality in patients with Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis of cohort studies. Rheumatology 55(3):450\u2013460","journal-title":"Rheumatology"},{"issue":"4","key":"5626_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/joim.13595","volume":"293","author":"G Sun","year":"2023","unstructured":"Sun G et al (2023) Long-term risk of heart failure and other adverse cardiovascular outcomes in primary Sj\u00f6gren\u2019s syndrome. J Intern Med 293(4):457\u2013469","journal-title":"J Intern Med"},{"issue":"4","key":"5626_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00005792-200207000-00004","volume":"81","author":"M Ramos-Casals","year":"2002","unstructured":"Ramos-Casals M et al (2002) Primary Sj\u00f6gren syndrome: hematologic patterns of disease expression. Med (Baltim) 81(4):281\u2013292","journal-title":"Med (Baltim)"},{"issue":"18","key":"5626_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.clinbiochem.2014.08.022","volume":"47","author":"ZD Hu","year":"2014","unstructured":"Hu ZD et al (2014) Red blood cell distribution width and neutrophil\/lymphocyte ratio are positively correlated with disease activity in primary Sj\u00f6gren\u2019s syndrome. Clin Biochem 47(18):287\u2013290","journal-title":"Clin Biochem"},{"issue":"3","key":"5626_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jbspin.2010.02.011","volume":"77","author":"W Cruz","year":"2010","unstructured":"Cruz W et al (2010) Is there a link between inflammation and abnormal lipoprotein profile in Sj\u00f6gren\u2019s syndrome? Joint Bone Spine 77(3):229\u2013231","journal-title":"Joint Bone Spine"},{"issue":"11","key":"5626_CR48","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/acr.21738","volume":"64","author":"KL Hackett","year":"2012","unstructured":"Hackett KL et al (2012) Impaired functional status in primary Sj\u00f6gren\u2019s syndrome. Arthritis Care Res (Hoboken) 64(11):1760\u20131764","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"5626_CR49","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.archger.2009.05.008","volume":"50","author":"M Cankurtaran","year":"2010","unstructured":"Cankurtaran M et al (2010) How to assess high erythrocyte sedimentation rate (ESR) in elderly? Arch Gerontol Geriatr 50(3):323\u2013326","journal-title":"Arch Gerontol Geriatr"},{"issue":"4","key":"5626_CR50","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ejr.2022.05.002","volume":"44","author":"A Abbasi Moghaddam","year":"2022","unstructured":"Abbasi Moghaddam A et al (2022) Hematologic parameters and disease activity in patients with primary Sj\u00f6gren\u2019s syndrome. Egypt Rheumatologist 44(4):329\u2013332","journal-title":"Egypt Rheumatologist"},{"key":"5626_CR51","doi-asserted-by":"publisher","first-page":"p3952392","DOI":"10.1155\/2019\/3952392","volume":"2019","author":"J Luo","year":"2019","unstructured":"Luo J et al (2019) High-risk indicators of renal involvement in primary Sjogren\u2019s syndrome: a clinical study of 1002 cases. J Immunol Res 2019:p3952392","journal-title":"J Immunol Res"},{"key":"5626_CR52","doi-asserted-by":"publisher","first-page":"562101","DOI":"10.3389\/fimmu.2020.562101","volume":"11","author":"G Ramponi","year":"2020","unstructured":"Ramponi G et al (2020) Biomarkers and diagnostic testing for renal disease in Sjogren\u2019s syndrome. Front Immunol 11:562101","journal-title":"Front Immunol"},{"issue":"3","key":"5626_CR53","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/gerona\/gln037","volume":"64","author":"MC Odden","year":"2009","unstructured":"Odden MC, Shlipak MG, Tager IB (2009) Serum creatinine and functional limitation in elderly persons. J Gerontol Biol Sci Med Sci 64(3):370\u2013376","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"5626_CR54","doi-asserted-by":"crossref","unstructured":"Alquaiz AM et al (2013) Prevalence of anemia and associated factors in child bearing age women in riyadh, saudi arabia J Nutr Metab, 2013: p. 636585","DOI":"10.1155\/2013\/636585"},{"key":"5626_CR55","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2147\/IJGM.S299450","volume":"14","author":"N AlFaris","year":"2021","unstructured":"AlFaris N et al (2021) Prevalence of Anemia and Associated Risk factors among non-pregnant women in Riyadh, Saudi Arabia: a cross-sectional study. Int J Gen Med 14:765\u2013777","journal-title":"Int J Gen Med"},{"issue":"5","key":"5626_CR56","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1124\/mol.117.109678","volume":"92","author":"AN Pronin","year":"2017","unstructured":"Pronin AN, Wang Q, Slepak VZ (2017) Teaching an Old Drug New tricks: Agonism, antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine receptor. Mol Pharmacol 92(5):601\u2013612","journal-title":"Mol Pharmacol"},{"key":"5626_CR57","doi-asserted-by":"crossref","unstructured":"Davies AN, Thompson J (2015) Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy. Cochrane Database Syst Rev, 2015(10): p. Cd003782.","DOI":"10.1002\/14651858.CD003782.pub3"},{"key":"5626_CR58","unstructured":"Panarese V, Moshirfar M (2023) Pilocarpine. StatPearls Publishing, Treasure Island (FL)"},{"issue":"Suppl 2","key":"5626_CR59","doi-asserted-by":"publisher","first-page":"S903","DOI":"10.4103\/jpbs.jpbs_236_21","volume":"13","author":"HA Alhejoury","year":"2021","unstructured":"Alhejoury HA et al (2021) Artificial Saliva for Therapeutic Management of Xerostomia: a narrative review. J Pharm Bioallied Sci 13(Suppl 2):S903\u2013s907","journal-title":"J Pharm Bioallied Sci"},{"key":"5626_CR60","doi-asserted-by":"crossref","unstructured":"Ingle EN (2020) Artificial Saliva for Therapeutic Management of Xerostomia: a structured review. J Oral Health Community Dentistry, 14(1)","DOI":"10.5005\/jp-journals-10062-0064"},{"key":"5626_CR61","doi-asserted-by":"crossref","unstructured":"Kim M et al (2021) Dry eye: why artificial tears are not always the answer. BMJ open Ophthalmol, 6(1)","DOI":"10.1136\/bmjophth-2020-000697"},{"key":"5626_CR62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajo.2020.05.043","volume":"219","author":"IJ Saldanha","year":"2020","unstructured":"Saldanha IJ et al (2020) Ocular manifestations and burden related to Sj\u00f6gren syndrome: results of a patient survey. Am J Ophthalmol 219:40\u201348","journal-title":"Am J Ophthalmol"},{"key":"5626_CR63","doi-asserted-by":"publisher","first-page":"693796","DOI":"10.3389\/fphar.2021.693796","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X et al (2021) The efficiency of hydroxychloroquine for the treatment of primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis. Front Pharmacol 12:693796","journal-title":"Front Pharmacol"},{"issue":"4","key":"5626_CR64","first-page":"237","volume":"38","author":"R Priori","year":"2020","unstructured":"Priori R, Mastromanno L, Izzo R (2020) What about glucocorticoids in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 38(4):237\u2013244","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"5626_CR65","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/rheumatology\/kew332","volume":"55","author":"SG Pasoto","year":"2016","unstructured":"Pasoto SG et al (2016) Cortical bone density and thickness alterations by high-resolution peripheral quantitative computed tomography: association with vertebral fractures in primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford) 55(12):2200\u20132211","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5626_CR66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00198-004-1639-9","volume":"16","author":"MS Ardawi","year":"2005","unstructured":"Ardawi MS et al (2005) Bone mineral density of the spine and femur in healthy saudis. Osteoporos Int 16(1):43\u201355","journal-title":"Osteoporos Int"},{"issue":"1","key":"5626_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.autrev.2018.06.015","volume":"18","author":"A Mirouse","year":"2019","unstructured":"Mirouse A et al (2019) Arthritis in primary Sj\u00f6gren\u2019s syndrome: characteristics, outcome and treatment from French multicenter retrospective study. Autoimmun Rev 18(1):9\u201314","journal-title":"Autoimmun Rev"},{"issue":"4","key":"5626_CR68","first-page":"10","volume":"38","author":"V Manfr\u00e8","year":"2020","unstructured":"Manfr\u00e8 V et al (2020) One year in review 2020: comorbidities, diagnosis and treatment of primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 38(4):10\u201322","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"5626_CR69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","volume":"42","author":"FB Vivino","year":"2016","unstructured":"Vivino FB et al (2016) New Treatment guidelines for Sj\u00f6gren\u2019s Disease. Rheum Dis Clin North Am 42(3):531\u2013551","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"5626_CR70","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/0961203307085255","volume":"17","author":"U Boonsrirat","year":"2008","unstructured":"Boonsrirat U et al (2008) Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3\u00a0C polymorphism. Lupus 17(2):132\u2013134","journal-title":"Lupus"},{"issue":"1","key":"5626_CR71","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/CND.0000000000000133","volume":"18","author":"KL Jack","year":"2016","unstructured":"Jack KL et al (2016) A review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis. J Clin Neuromuscul Dis 18(1):12\u201320","journal-title":"J Clin Neuromuscul Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05626-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05626-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T14:08:03Z","timestamp":1718374083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05626-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":71,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["5626"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05626-0","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"assertion":[{"value":"24 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was made freely available through Open Access funding.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Open access funding"}}]}}